How stress-related DNA breaks change brain cells and thinking

The impact of stress-induced DNA breaks on chromatin structure, gene activity, and neuron function

['FUNDING_R01'] · UNIVERSITY OF CINCINNATI · NIH-11250021

This work looks at whether repeated stress causes DNA breaks in brain cells that alter gene activity and connections in ways relevant to people with depression or PTSD.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorUNIVERSITY OF CINCINNATI (nih funded)
Locations1 site (CINCINNATI, UNITED STATES)
Trial IDNIH-11250021 on ClinicalTrials.gov

What this research studies

Researchers use mouse models of chronic stress to see how stress produces DNA double-strand breaks in neurons inside brain areas that control mood and thinking, like the prefrontal cortex and hippocampus. They map how those breaks change chromatin structure and which genes are turned on using advanced chromosome-mapping (3C/4C) and gene-activity techniques. The team examines the role of the enzyme Top2B and tests how reducing neuronal activity with drugs (shown earlier with diazepam) affects DNA breaks, synapses, and behavior. Findings are linked across molecules, neuron structure, and behavior to point toward mechanisms that could matter for stress-related psychiatric symptoms.

Who could benefit from this research

Good fit: This is a lab-based, preclinical project that does not enroll people, but its results are most relevant to individuals with chronic stress, major depressive disorder, or PTSD.

Not a fit: People without stress-related mood or anxiety conditions—or whose symptoms arise from unrelated medical causes—are unlikely to see direct benefits from this specific basic-science project.

Why it matters

Potential benefit: If successful, this work could reveal molecular steps by which stress damages brain circuits and point to new targets to prevent or reverse stress-related cognitive and mood problems.

How similar studies have performed: Prior animal studies have shown stress triggers neuronal DNA breaks and early work found that suppressing neuronal activity (e.g., with diazepam) lowers those breaks, but translation to human treatments is still unproven.

Where this research is happening

CINCINNATI, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.